CURACYTE DISCOVERY GMBH
Curacyte Discovery GmbH is a biopharmaceutical company which develops selective inhibitors of urokinase-type plasminogen activator.
CURACYTE DISCOVERY GMBH
Industry:
Biotechnology Pharmaceutical
Address:
Jena, Thuringen, Germany
Country:
Germany
Status:
Active
Contact:
+493641508515
More informations about "Curacyte Discovery GmbH"
Curacyte Discovery GmbH - Crunchbase Company Profile & Funding
Organization. Curacyte Discovery GmbH . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. ... Curacyte Discovery GmbH is a biopharmaceutical …See details»
Curacyte Sells Its Subsidiary Curacyte Discovery GmbH to The …
Aug 6, 2008 Curacyte Discovery GmbH, is a wholly-owned subsidiary of Curacyte AG. Curacyte AG is an advanced biopharmaceutical company dedicated to the development of new …See details»
Curacyte AG Sells Its Subsidiary Curacyte Discovery GmbH to
MUNICH, Germany--(BUSINESS WIRE)--Curacyte AG today announced that it has sold its wholly owned subsidiary, Curacyte Discovery GmbH based in Leipzig (Germany) to The Medicines …See details»
Curacyte Discovery - Ownership and Business Overview - Mergr
Curacyte Discovery is owned by The Medicines Company. It was acquired on August 4, 2008. Pricing; Log In; Pro - Try 1 Week Free; ... Curacyte Discovery GmbH. Deutscher Platz 5d, …See details»
Curacyte 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Curacyte. Use the PitchBook Platform to explore the full profile. ... C/o Dornbach GmbH; Arnulfstraße 39; 80636 …See details»
Curacyte Sells Subsidiary | PE Hub
Aug 6, 2008 Curacyte AG has sold subsidiary Curacyte Discovery GmbH, which develops a compound for the prevention of blood loss during surgery, to The Medicines Co. (Nasdaq: …See details»
The Medicines Company (Leipzig) GmbH, Leipzig - North Data
Geschäftsführer (1 Person) · Name: Curacyte Discovery GmbH · Unternehmensgegenstand 02.06.2005 als Curacyte Discovery GmbH 10.02.2005 als IBFB Pharma GmbHSee details»
Medicines Co. buys Curacyte subsidiary | Fierce Biotech
Aug 6, 2008 The Medicines Company is buying Curacyte subsidiary Curacyte Discovery for €14.5 million up front. Curacyte Discovery is developing a serine protease inhibitor in the area …See details»
The Medicines Company Leipzig GmbH Company Profile
The Medicines Company (Leipzig) GmbH, a research-based biopharmaceutical company, provides development of synthetic serine protease inhibitors in the area of hemostasis and anti …See details»
Medicines Company acquires German-based Curacyte Discovery
Aug 7, 2008 The Medicines Company has acquired German-based Curacyte Discovery GmbH and its lead compound, CU-2010, which is being developed for the prevention of surgical …See details»
Curacyte Discovery GmbH acquired by The Medicines Company
The Medicines Company acquires Curacyte Discovery GmbH on 2008-08-05 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
Curacyte Sells Its Subsidiary Curacyte Discovery GmbH to The
Aug 5, 2008 Curacyte Discovery GmbH, is a wholly-owned subsidiary of Curacyte AG. Curacyte AG is an advanced biopharmaceutical company dedicated to the development of new …See details»
The Medicines Company erwirbt Curacyte Discovery
Durch die Akquisition der Curacyte Discovery GmbH erwirbt The Medicines Company integrierte Entwicklungskompetenz auf dem Gebiet von Serinprotease-Hemmstoffen. Diese …See details»
The Medicines Company erwirbt CU-2010 und Curacyte Discovery
The Medicines Company hat bekanntgegeben, dass sie die Curacyte Discovery GmbH mit Sitz in Leipzig, sowie deren Wirkstoffkandidat CU-2010 erworben hat. CU-2010 wird zur Reduktion …See details»
Curacyte AG - Ownership and Business Overview - Mergr
Curacyte GmbH is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. M&A Summary. Buy vs Sell. Year ≤ '20 ...See details»
The Medicines Company Acquires CU?2010 and Curacyte …
Aug 6, 2008 The Medicines Company (NASDAQ: MDCO) today announced that it has acquired German–based Curacyte Discovery GmbH and its lead compound, CU–2010, which is being …See details»
The Medicines Company Picks Up Curacyte’s Subsidiary Curacyte …
Aug 6, 2008 The Medicines Company paid €14.5 million, or $22.34 million, for Curacyte’s subsidiary Curacyte Discovery, which focuses on synthetic serine protease inhibitors in the …See details»
The Medicines Company - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2015: Post-IPO Debt - …See details»
Acquireprime - Curacyte Discovery GmbH
Curacyte Discovery GmbH. Sector: Life Science. Basic Information. Contact Information Deutscher Platz 5d Leipzig,04103, Germany. Details Full name : Curacyte Discovery GmbH …See details»
Curacyte - Products, Competitors, Financials, Employees, …
Curacyte is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care. Use the CB Insights Platform to explore Curacyte's full …See details»